| Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer B Bueschbell, AB Caniceiro, PMS Suzano, M Machuqueiro, ... Drug Resistance Updates 60, 100811, 2022 | 39 | 2022 |
| SARS-CoV-2 membrane protein: from genomic data to structural new insights C Marques-Pereira, MN Pires, RP Gouveia, NN Pereira, AB Caniceiro, ... International Journal of Molecular Sciences 23 (6), 2986, 2022 | 31 | 2022 |
| Class A and C GPCR dimers in neurodegenerative diseases AB Caniceiro, B Bueschbell, AC Schiedel, IS Moreira Current Neuropharmacology 20 (11), 2081-2141, 2022 | 10 | 2022 |
| MUG: A mutation overview of GPCR subfamily A17 receptors AB Caniceiro, B Bueschbell, CAV Barreto, AJ Preto, IS Moreira Computational and Structural Biotechnology Journal 21, 586-600, 2023 | 2 | 2023 |
| POSEIDON: Peptidic Objects SEquence-based Interaction with cellular DOmaiNs: a new database and predictor AJ Preto, AB Caniceiro, F Duarte, H Fernandes, L Ferreira, J Mourão, ... Journal of Cheminformatics 16 (1), 18, 2024 | 1 | 2024 |
| Leveraging Artificial Intelligence in GPCR Activation Studies: Computational Prediction Methods as Key Drivers of Knowledge AB Caniceiro, U Orzeł, N Rosário-Ferreira, S Filipek, IS Moreira Protein Supersecondary Structures: Methods and Protocols, 183-220, 2024 | | 2024 |
| A big data approach to understand mutagenesis effect on the GPCR Subfamily A17 ABR Caniceiro A big data approach to understand mutagenesis effect on the GPCR Subfamily A17, 2022 | | 2022 |
| O Papel dos Halogénios no Desenho de Fármacos: O Caso da Ligação de Pequenos Ligantes à Transtirretina ABR Caniceiro PQDT-Global, 2019 | | 2019 |
| PC1–Ana B. Carniceiro AB Caniceiro, B Bueschbell, IS Moreira 3D-BIOINFO-PT, 35, 0 | | |